Latest News & Features
Big Pharma
Law firm HGF has added Leythem Wall as a partner. 22 January 2019
Americas
The US Patent and Trademark Office has declined to hear two petitions filed by Switzerland-based Novartis to review two patents owned by drug discovery company Plexxikon. 21 January 2019
Big Pharma
Novartis and the University of Oxford’s Big Data Institute have joined forces to use artificial intelligence for improving drug development, initially in the areas of multiple sclerosis, dermatology and rheumatology. 21 January 2019
Americas
Canadian cannabis manufacturing company, Chemesis International, has signed an agreement with GSRX Industries, a Puerto-Rico based dispensary, to manufacture an edible cannabis product on the island. 18 January 2019
Americas
US-based Insys Therapeutics has succeeded in its bid to prove that two of the claims in a patent owned by British company GW Pharmaceuticals were covered by a prior invention. 17 January 2019
Big Pharma
Lawyers have told LSIPR they are concerned about the continuing UK political uncertainty having a negative impact on life sciences investment and the Unified Patent Court. 17 January 2019
Americas
US-based medical technology company GE Healthcare has entered into a five-year partnership with Vanderbilt University Medical Center to develop cancer immunotherapies using artificial intelligence. 17 January 2019
Americas
The US Food and Drug Administration has announced new policies to advance the development of safe and effective cell and gene therapies. 16 January 2019
Medtech
Boston Scientific and US-based Edwards Lifesciences have agreed to settle all outstanding patent litigation between the two companies. 15 January 2019
Americas
US law firm McGuire Woods is expanding its life sciences patent litigation team with the addition of three partners in its New York office. 15 January 2019